Geraldo R C Pinheiro Selected Research

Necrosis

5/2015

Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Geraldo R C Pinheiro Research Topics

Disease

5	Rheumatoid Arthritis 01/2022 - 05/2015
2	Rheumatic Diseases (Rheumatism) 03/2020 - 05/2015
1	Rheumatic Fever (Acute Articular Rheumatism) 06/2021
1	Infections 03/2020
1	Gout 01/2019
1	Inflammation (Inflammations) 01/2019
1	Necrosis 05/2015
1	Ankylosing Spondylitis 05/2015

Drug/Important Bio-Agent (IBA)

3	Biological ProductsIBA 10/2021 - 05/2015
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 10/2021
2	Leflunomide (Arava)FDA LinkGeneric 01/2022 - 10/2021
2	Antirheumatic Agents (DMARD)IBA 10/2021 - 03/2020
1	Janus Kinase InhibitorsIBA 10/2021
1	PTX3 proteinIBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	CytokinesIBA 01/2019
1	Pharmaceutical PreparationsIBA 05/2015

Therapy/Procedure

2	Biological Therapy 03/2020 - 05/2015
1	Polypharmacy 06/2021
1	Therapeutics 05/2015